People: Geron Corp (GERN.OQ)

GERN.OQ on NASDAQ Stock Exchange Global Select Market

2 Oct 2015
Change (% chg)

$0.32 (+11.90%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Search Stocks

Kelly Behrs, Melissa 

Ms. Melissa A. Kelly Behrs is Executive Vice President - Business Development and Portfolio and Alliance Management of the Company. Melissa A. Kelly Behrs has served as our Executive Vice President, Business Development and Portfolio & Alliance Management, since July 2014. Prior to that she was our Executive Vice President, Portfolio and Alliance Management, since February 2014 and she was our Senior Vice President, Portfolio and Alliance Management, from September 2012 to February 2014. Ms. Behrs joined Geron in November 1998 as Director of Corporate Development. Since then, she has served in various managerial positions, including General Manager, R&D Technologies; Vice President, Corporate Development; Senior Vice President, Therapeutic Development, Oncology; and Senior Vice President, Strategic Portfolio Management. From 1990 to 1998, Ms. Behrs worked at Genetics Institute, Inc., a biotechnology research and development company, serving initially as Assistant Treasurer and then as Associate Director of Preclinical Operations where she was responsible for all business development, regulatory, and project management activities for the Preclinical Development function. Ms. Behrs received a B.S. from Boston College and an M.B.A. from Babson College.

Basic Compensation

Total Annual Compensation, USD 367,840
Restricted Stock Awards, USD --
Long-Term Incentive Plans, USD --
All Other, USD 1,674,720
Fiscal Year Total, USD 2,042,560

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Hoyoung Huh


John Scarlett


Olivia Bloom


Stephen Rosenfield


Andrew Grethlein


Melissa Kelly Behrs

As Of  30 Dec 2014
Search Stocks